S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
OTCMKTS:EHVVF

EHAVE Stock Forecast, Price & News

$0.18
+0.01 (+5.97 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.16
Now: $0.18
$0.19
50-Day Range
$0.03
MA: $0.12
$0.19
52-Week Range
$0.02
Now: $0.18
$1.10
Volume3.39 million shs
Average Volume1.37 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
EHAVE, Inc., a healthcare company, develops medical cannabis and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada. The company offers MegaTeam and Ninja Reflex, a clinically validated digital assessment and rehabilitation software for the patient; and adapts custom and third-party clinically validated digital assessment and rehabilitation software for enhanced patient engagement and data modeling. It provides its technology solutions to clinicians, patients, researchers, pharmaceutical companies, and payors. The company has a partnership with identity key to provide blockchain based identity verification software for the medical industry. EHAVE, Inc. was incorporated in 2011 and is based in Aventura, Florida.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Computer And Technology Sector

1353rd out of 1,501 stocks

Software—Application Industry

28th out of 37 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Software—Application
Sub-IndustryN/A
Current SymbolOTCMKTS:EHVVF
CUSIPN/A
CIKN/A
Phone954 233 3511
Employees1
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.18
+0.01 (+5.97 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EHVVF News and Ratings via Email

Sign-up to receive the latest news and ratings for EHVVF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











EHAVE (OTCMKTS:EHVVF) Frequently Asked Questions

What stocks does MarketBeat like better than EHAVE?

Wall Street analysts have given EHAVE a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but EHAVE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting EHAVE?

EHAVE saw a increase in short interest in December. As of December 31st, there was short interest totaling 36,200 shares, an increase of 273.2% from the December 15th total of 9,700 shares. Based on an average trading volume of 3,421,900 shares, the days-to-cover ratio is currently 0.0 days.
View EHAVE's Short Interest
.

Who are some of EHAVE's key competitors?

Who are EHAVE's key executives?

EHAVE's management team includes the following people:
  • Mr. Benjamin Kaplan, Chairman, Pres & CEO (Age 52, Pay $174.15k)
  • Mr. Alfred Farrington II, Chief Information Officer

What is EHAVE's stock symbol?

EHAVE trades on the OTCMKTS under the ticker symbol "EHVVF."

How do I buy shares of EHAVE?

Shares of EHVVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is EHAVE's stock price today?

One share of EHVVF stock can currently be purchased for approximately $0.18.

What is EHAVE's official website?

The official website for EHAVE is www.ehave.com.

How can I contact EHAVE?

The company can be reached via phone at 954 233 3511.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.